The potential of methylethylpiridinol in treatment of bacterial infections caused by Klebsiella pneumoniae (experimental study)

Aim. Investigated the activity of methylethylpiridinol (6-methyl-2-ethyl-pyridin-3-ol hydrochloride) in the comprehensive treatment of the experimental bacterial infection caused by Klebsiella pneumoniae.Materials and methods. The study was conducted on clinical isolates of Klebsiella pneumoniae. At...

Full description

Bibliographic Details
Main Authors: V. M. Brykhanov, A. G. Miroshnichenko
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2016-10-01
Series:Bûlleten' Sibirskoj Mediciny
Subjects:
Online Access:https://bulletin.tomsk.ru/jour/article/view/660
id doaj-375a4d2d3ed0447daa6df13b4750fb06
record_format Article
spelling doaj-375a4d2d3ed0447daa6df13b4750fb062021-07-29T08:38:03ZengSiberian State Medical University (Tomsk)Bûlleten' Sibirskoj Mediciny1682-03631819-36842016-10-01154111910.20538/1682-0363-2016-4-11-19579The potential of methylethylpiridinol in treatment of bacterial infections caused by Klebsiella pneumoniae (experimental study)V. M. Brykhanov0A. G. Miroshnichenko1Altai State Medical University 40, Av. Lenina, Barnaul, 656038, Russian FederationAltai State University 61, Av. Lenina, Barnaul, 656049, Russian FederationAim. Investigated the activity of methylethylpiridinol (6-methyl-2-ethyl-pyridin-3-ol hydrochloride) in the comprehensive treatment of the experimental bacterial infection caused by Klebsiella pneumoniae.Materials and methods. The study was conducted on clinical isolates of Klebsiella pneumoniae. At the first stage of the study (in vitro) studied the effect of methylethylpiridinol in concentrations 0,25–4 mM on the growth of the strain and the activity of the sublethal concentrations of antibiotics – gentamicin, ciprofloxacin, tetracycline, ceftazidime. In the second stage of the study (in vivo) in rats Wistar simulated bacterial peritonitis by intraperitoneal injection of a suspension of Klebsiella pneumoniae and investigated the effect of methylethylpiridinol (80 mg/kg) on the effectiveness of antibiotic therapy with gentamicin (30 mg/kg), ciprofloxacin (50 mg/kg), ceftazidime (120 mg/kg) or tetracycline (80 mg/kg). The animal blood plasma was determined ceruloplasmin concentration (marker of the intensity of infectious-inflammatory process) and thiobarbiturate-jet products, erythrocytes – the concentration of reduced glutathione, catalase and glutathione peroxidase.Results. It is found that a methylethylpiridinol inhibits the development of periodic bacterial cultures, but exhibits a pronounced antagonism with respect to gentamicin. Antioxidant slightly increases the activity of ciprofloxacin and tetracycline. The bacteriostatic effect of antioxidant reduces the action of ceftazidime in vitro. In conditions of chemotherapy by using of gentamicin and ciprofloxacin additional injection of methylethylpiridinol leads to the preservation of ceruloplasmin level to the level of non-treated animals without showing the antioxidant effect. Ceftazidime exhibits antioxidant effect, reduces the introduction of methylethylpiridinol. The antioxidant properties of methylethylpiridinol did not appear in the application of tetracycline.Conclusion. Comparison of results in vitro and in vivo confirmed irrationality of using of methylethylpiridinol in chemotherapy with gentamicin, ciprofloxacin, ceftazidime or tetracycline for correction of peroxidation in experimental infection caused by Klebsiella pneumoniae. Methylethylpiridinol in experimental chemotherapy has no law-governed effect on free radical oxidation, and when applied gentamicin may cause reduction the effectiveness of chemotherapy, confirmed in vitro.https://bulletin.tomsk.ru/jour/article/view/660antioxidantsantibacterial drugsklebsiella pneumoniaedrug interactions
collection DOAJ
language English
format Article
sources DOAJ
author V. M. Brykhanov
A. G. Miroshnichenko
spellingShingle V. M. Brykhanov
A. G. Miroshnichenko
The potential of methylethylpiridinol in treatment of bacterial infections caused by Klebsiella pneumoniae (experimental study)
Bûlleten' Sibirskoj Mediciny
antioxidants
antibacterial drugs
klebsiella pneumoniae
drug interactions
author_facet V. M. Brykhanov
A. G. Miroshnichenko
author_sort V. M. Brykhanov
title The potential of methylethylpiridinol in treatment of bacterial infections caused by Klebsiella pneumoniae (experimental study)
title_short The potential of methylethylpiridinol in treatment of bacterial infections caused by Klebsiella pneumoniae (experimental study)
title_full The potential of methylethylpiridinol in treatment of bacterial infections caused by Klebsiella pneumoniae (experimental study)
title_fullStr The potential of methylethylpiridinol in treatment of bacterial infections caused by Klebsiella pneumoniae (experimental study)
title_full_unstemmed The potential of methylethylpiridinol in treatment of bacterial infections caused by Klebsiella pneumoniae (experimental study)
title_sort potential of methylethylpiridinol in treatment of bacterial infections caused by klebsiella pneumoniae (experimental study)
publisher Siberian State Medical University (Tomsk)
series Bûlleten' Sibirskoj Mediciny
issn 1682-0363
1819-3684
publishDate 2016-10-01
description Aim. Investigated the activity of methylethylpiridinol (6-methyl-2-ethyl-pyridin-3-ol hydrochloride) in the comprehensive treatment of the experimental bacterial infection caused by Klebsiella pneumoniae.Materials and methods. The study was conducted on clinical isolates of Klebsiella pneumoniae. At the first stage of the study (in vitro) studied the effect of methylethylpiridinol in concentrations 0,25–4 mM on the growth of the strain and the activity of the sublethal concentrations of antibiotics – gentamicin, ciprofloxacin, tetracycline, ceftazidime. In the second stage of the study (in vivo) in rats Wistar simulated bacterial peritonitis by intraperitoneal injection of a suspension of Klebsiella pneumoniae and investigated the effect of methylethylpiridinol (80 mg/kg) on the effectiveness of antibiotic therapy with gentamicin (30 mg/kg), ciprofloxacin (50 mg/kg), ceftazidime (120 mg/kg) or tetracycline (80 mg/kg). The animal blood plasma was determined ceruloplasmin concentration (marker of the intensity of infectious-inflammatory process) and thiobarbiturate-jet products, erythrocytes – the concentration of reduced glutathione, catalase and glutathione peroxidase.Results. It is found that a methylethylpiridinol inhibits the development of periodic bacterial cultures, but exhibits a pronounced antagonism with respect to gentamicin. Antioxidant slightly increases the activity of ciprofloxacin and tetracycline. The bacteriostatic effect of antioxidant reduces the action of ceftazidime in vitro. In conditions of chemotherapy by using of gentamicin and ciprofloxacin additional injection of methylethylpiridinol leads to the preservation of ceruloplasmin level to the level of non-treated animals without showing the antioxidant effect. Ceftazidime exhibits antioxidant effect, reduces the introduction of methylethylpiridinol. The antioxidant properties of methylethylpiridinol did not appear in the application of tetracycline.Conclusion. Comparison of results in vitro and in vivo confirmed irrationality of using of methylethylpiridinol in chemotherapy with gentamicin, ciprofloxacin, ceftazidime or tetracycline for correction of peroxidation in experimental infection caused by Klebsiella pneumoniae. Methylethylpiridinol in experimental chemotherapy has no law-governed effect on free radical oxidation, and when applied gentamicin may cause reduction the effectiveness of chemotherapy, confirmed in vitro.
topic antioxidants
antibacterial drugs
klebsiella pneumoniae
drug interactions
url https://bulletin.tomsk.ru/jour/article/view/660
work_keys_str_mv AT vmbrykhanov thepotentialofmethylethylpiridinolintreatmentofbacterialinfectionscausedbyklebsiellapneumoniaeexperimentalstudy
AT agmiroshnichenko thepotentialofmethylethylpiridinolintreatmentofbacterialinfectionscausedbyklebsiellapneumoniaeexperimentalstudy
AT vmbrykhanov potentialofmethylethylpiridinolintreatmentofbacterialinfectionscausedbyklebsiellapneumoniaeexperimentalstudy
AT agmiroshnichenko potentialofmethylethylpiridinolintreatmentofbacterialinfectionscausedbyklebsiellapneumoniaeexperimentalstudy
_version_ 1721253336865308672